title: Battle over generic taxol concludes, but controversy continues.
authors.forename: Ken
authors.initials: K
authors.lastname: Garber
mesh_terms: D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000331:legislation & jurisprudence; D016568:Drugs, Generic / Q000627:therapeutic use; D006801:Humans; D007880:Legislation, Drug; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000627:therapeutic use; D014481:United States
chemical_list: D016568:Drugs, Generic; D017239:Paclitaxel